Deer VII & Co’s Tempest Therapeutics TPST Stock Holding History

Deer VII & Co’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-82	Closed	-$6.92M	–	7
2015 Q2	$6.92M	Hold	82	–	–	2.83%	4
2015 Q1	$8.31M	Sell	82 -711	-90%	-$94.7M	3.41%	4
2014 Q4	$103M	Hold	793	–	–	30.57%	2
2014 Q3	$38.5M	Sell	793 -25	-3%	-$876K	17.15%	3
2014 Q2	$21.9M	Hold	818	–	–	6.19%	4
2014 Q1	$19.2M	Hold	818	–	–	5.02%	4
2013 Q4	$21.9M	Hold	818	–	–	5.28%	4
2013 Q3	$22.2M	Hold	818	–	–	44.61%	1
2013 Q2	$30.8M	Buy	+818	New	+$30.7M	45.62%	1

Other funds holding TPST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deer VII & Co's TPST Position: Q3 2015 in Review

Deer VII & Co sold out of Tempest Therapeutics (TPST) in Q3 2015, closing a stake of 82 shares — an estimated $6.92M sold.

Deer VII & Co first reported a position in TPST in Q2 2013 and held it in 9 quarters. The position peaked at $103M in Q4 2014. 90 funds tracked by Wall St. Rank hold TPST as of Q3 2015.

Deer VII & Co reported no remaining Tempest Therapeutics position as of Q3 2015 after selling out during the quarter.
Deer VII & Co sold 82 Tempest Therapeutics shares in Q3 2015, an estimated $6.92M.
Deer VII & Co first reported a position in Tempest Therapeutics in Q2 2013 and held it in 9 quarters.
Deer VII & Co's Tempest Therapeutics position peaked at $103M in Q4 2014.
90 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2015.

Based on Deer VII & Co's 13F filing for Q3 2015, filed 13 Nov 2015.